Skip to main content

Table 1 Baseline characteristics of the participants

From: N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

  Placebo (n = 21) n3 FA (n = 20) P
Mean ± SD Mean ± SD
Age (years) 60.91 ± 8.56 60.32 ± 9.53 0.830
BMI (kg/m2) 24.10 ± 2.94 23.50 ± 3.17 0.525
Gender, n (%) Female 8 (36.4) 8 (36.4)  
Male 14 (63.6) 14 (63.6)
Patients on OADs (%)   12 (57.1) 10 (50.0)  
Patients on AHDs (%)   16 (76.1) 14 (70.0)  
  1. Definitions – BMI Body mass index, OADs Oral antidiabetic drugs, AHDs Antihypertensive drugs